tirzepatide semaglutide side effects vs. Semaglutide: What You Should Know Tirzepatide vs Semaglutide Side Effects:

Kolotkin RL, Williams VSL, Ervin CM, et al

Never freeze tirzepatide

2021;137(6):e128-e144

The combined effect of activating both receptors seems to create a synergistic effect, where the benefits are greater than simply adding them together

For example, instead of 10 mg once weekly, you might inject 5 mg twice weekly (separated by 3-4 days)

In general, semaglutide (Wegovy ) and tirzepatide (Zepbound ) are FDA-approved for weight loss in people with: A BMI of 30 or higher , or A BMI of 27 or higher with at least one weight-related condition, like type 2 diabetes or high blood pressure Each medication also has additional FDA-approved uses beyond weight loss: Wegovy is also approved to reduce the risk of major cardiovascular events like heart attack and stroke in adults with cardiovascular disease